Detalhe da pesquisa
1.
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer.
Nature
; 2024 Apr 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38588696
2.
Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer.
Hum Mutat
; 28(12): 1207-15, 2007 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-17688236